Promotional material

Vaccine update: issue 349, September 2024, flu special

Published 11 September 2024

Applies to England

© Crown copyright 2024

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/vaccine-update-issue-349-september-2024-flu-special/vaccine-update-issue-349-september-2024-flu-special

Flu vaccination programme – 2024 to 2024

Flu vaccination is a critically important public health intervention and a key priority for reducing morbidity, mortality and hospitalisation associated with flu during the winter period when the NHS and social care are under pressure.

Eligibility for this autumn’s vaccination programme has not changed since last year. Those in clinical risk groups, older adults, and pregnant women are eligible alongside the offer as part of the children’s programme to 2 and 3-year-olds, all primary school-aged children, and secondary school-aged children up to Year 11.

This year there has been a change to when the flu vaccination programme for adults starts, with most adults to be offered a vaccine from 3 October. The only exceptions to this later start date are for pregnant women and children who should continue to be offered vaccination from September, and under exceptional clinical circumstances where earlier vaccination may be appropriate – see section below on timing for more information. The start date for COVID-19 vaccinations aligns to flu to support co-administration of flu and COVID-19 vaccines.

This Vaccine update Flu special sets out the eligibility criteria for this year’s programme. It provides links to Influenza: the Green Book, chapter 19. It also contains the Joint Committee on Vaccination and Immunisation (JCVI) advice on flu vaccines and timing of the programme, the Patient Group Directions (PGDs), and training materials for healthcare professionals. It outlines how to download or order free of charge, our patient and parent-facing resources which include leaflets, letter templates, consent forms and posters, with leaflets translated into over 30 languages and provided in Braille, British Sign Language, large print, simple text for those with low literacy, and easy read for those with a learning disability.

A winter vaccinations communications campaign will begin in September once flu vaccination starts being offered to children and pregnant women. This will be light touch at the beginning ramping up through September with a national paid-for marketing campaign launching the week commencing 7 October, encouraging the uptake of influenza and COVID-19 vaccines, once all adults are eligible from 3 October. There will also be activity aimed at encouraging pregnant women to get the pertussis and RSV vaccines when eligible.

We would like to extend our thanks to all for their hard work delivering the programme.

Timing of flu vaccination

Based on the evidence that flu vaccine’s effectiveness can wane over time in adults, the JCVI has advised moving the start of the programme for most adults to the beginning of October, and NHS England have confirmed a start date of 3 October. It is preferable to vaccinate individuals closer to the time when the flu virus is likely to circulate (which typically peaks in December or January), as this will provide optimal protection during the highest risk period. The majority of the vaccinations will need to be completed by the end of November.

Protection from the vaccine lasts much longer in children, therefore the priority is to start vaccinating all children (including those in clinical risk groups) from 1 September, or as soon as vaccine becomes available, both to provide early protection to children and reduce transmission to the wider population. For school-aged cohorts, vaccination should be completed by Friday 13 December 2024.

Pregnant women are an exception to the later start date. There are 3 clinical reasons to vaccinate pregnant women against flu:

  • to protect the pregnant women themselves (they are at higher risk from complications from flu)
  • to protect the baby during pregnancy (for example, flu infection increases the risks of the baby being premature or stillborn)
  • to protect the baby in the first few months of life (babies under 6 months old are at high risk of complications from flu)

Although the first and second of these reasons would align with the advice to provide maximal protection during the expected flu season, the third reason requires women to be vaccinated prior to delivery and therefore vaccination of pregnant women should begin from 1 September. Pregnant women are not expected to lose protection as rapidly as the elderly population, and therefore starting vaccination (particularly in those women who are in the later stages of pregnancy) earlier than for those in other clinical risk groups will still offer protection to women themselves in the peak season. Commencing vaccination early will, however, ensure that as many newborn babies as possible are protected during the flu season and help to optimise uptake.

Following clinical assessment, there may be a small number of other adults for whom it would be better not to delay flu vaccination until October. For example, for those who are due to commence immunosuppressive treatment (such as chemotherapy) before October, having flu vaccine before they start treatment would allow them to make a better response to their vaccination. GPs should use clinical judgement to bring forward vaccination in exceptional circumstances, as outlined in the Green Book, and offer vaccination as soon as the vaccine becomes available, in line with contractual arrangements.

We appreciate that for those adults who have been used to getting their annual flu vaccine in September, this may lead to questions and potential confusion about why they are having to wait. To help explain this change, UKHSA has produced a flyer, ‘When should I get my flu vaccination’, available to print and download for free using product code 24FLUWEN.

Who is eligible?

The following are eligible for an NHS vaccine in 2024 to 2025:

From 1 September:

  • pregnant women
  • all children aged 2 or 3 years old (on 31 August 2024)
  • all primary school-aged children (from Reception class to Year 6)
  • secondary school-aged children from Years 7 to 11
  • all children in clinical risk groups aged from 6 months to less than 18 years

From 3 October 2024:

  • those aged 18 to under 65 years in clinical risk groups such as those below
  • those aged 65 years and over
  • those in long-stay residential care homes
  • carers in receipt of carer’s allowance, or those who are the main carer of an elderly or disabled person
  • close contacts of immunocompromised individuals
  • locum GPs[footnote 1]
  • frontline staff employed by the types of social care providers without employer-led occupational health schemes such as those described below
  • those living in long-stay residential care homes or nursing homes[footnote 1], other long-stay health or social care facilities[footnote 1] or a house-bound patient (defined in the ES specification)

Examples of clinical risk groups

  • chronic (long-term) respiratory disease, such as asthma (requires continuous or repeated use of inhaled or systemic steroids or with previous exacerbations requiring hospital admission), chronic obstructive pulmonary disease (COPD) or bronchitis
  • chronic neurological disease, such as Parkinson’s disease or motor neurone disease
  • a weakened immune system due to disease (such as HIV/AIDS) or treatment (such as cancer treatment)
  • morbidly obese (defined as BMI of 40 and above)
  • chronic heart disease, such as heart failure
  • chronic kidney disease at stage 3, 4 or 5
  • chronic liver disease
  • a learning disability
  • diabetes and adrenal insufficiency
  • splenic dysfunction or asplenia

Examples of social care providers without employer-led occupational health schemes

  • registered domiciliary care provider
  • direct payment (personal budgets) and/or personal health budgets, such as personal assistants
  • a registered residential care/nursing home[footnote 1]
  • a voluntary managed hospice provider[footnote 1]

For further information, see:

Frontline health and social care workers

All frontline healthcare workers, including both clinical and non-clinical staff who have contact with patients, should be offered a flu vaccine for the prevention of the transmission of flu to help protect both staff and those that they care for. Vaccination of frontline healthcare workers for flu continues to be an employer responsibility without an activity-based payment.

Social care workers directly working with people clinically vulnerable to flu should also have the flu vaccine provided by their employer. There are circumstances where frontline staff, employed by specific social care providers without access to employer-led occupational health schemes (see eligibility criteria), can access the vaccine through the NHS free of charge

Additional information on flu immunisation is available to download and order online, for:

  • social care staff, using product code F23SCSEN2
  • personal assistants, using product code F23SCPAEN3
  • hospice providers, using product code F23SCPEN1

Marketing assets to support flu and COVID-19 vaccination of healthcare workers will be available to order from the Campaign Resource Centre.

Influenza: the Green Book, chapter 19

The influenza chapter in the Green Book gives detailed descriptions about clinical risk groups advised to receive influenza vaccination and guidance for healthcare workers on administering the influenza vaccine.

Which flu vaccine should be offered?

Every year the JCVI reviews the latest evidence on influenza vaccines and recommends the type of vaccine to be offered to individuals. For 2024 to 2025 no changes were made to the recommendations either for children or adults. NHSE confirmed which vaccines will be reimbursed on the NHS as part of the tripartite annual flu letter for the 2024 to 2025 season – please see amendment to the flu letter of 12 June 2024.

Which flu vaccines poster 2024 to 2025 season

A list of all influenza vaccines marketed in the UK (including details of ovalbumin content) is available.

Which flu vaccine should children be given poster

A poster for practices summarising which flu vaccine should be given to eligible/clinical risk groups, with images of the manufacturer’s box for each vaccine, is available to download.

A quick reference guide to the childhood flu vaccines for winter 2024 to 2025, download only, is also available.

Guidance on immunisation training for 2024 to 2025 influenza season

All healthcare professionals involved in administering the influenza vaccine must have the necessary knowledge, skills, training and mechanisms in place to supply and safely administer influenza vaccines.

The updated flu immunisation training recommendations were published in August 2024. These include recommended training requirements by workforce group for influenza vaccination, suggested content that should be covered in theoretical and/or work-based training and a competency assessment tool for new influenza vaccinators.

If training is not available locally, all those who advise on or administer influenza vaccines are recommended to complete the flu-specific e-learning programme which is updated annually and is available free of charge with open access for all. This e-learning programme consists of a core knowledge module, separate modules on the inactivated and live influenza vaccines and accompanying knowledge assessments for each module.

The national flu immunisation programme for 2024 to 2025 slideset is available to download from the main annual flu programme page, and ‘Flu vaccination programme 2024 to 2025: information for healthcare practitioners’, containing information about the current influenza programme, the vaccines available and commonly raised issues for influenza vaccination has also been published.

Patient Group Directions

Patient Group Directions (PGDs) for the 2024 to 2025 influenza season are available via the main webpage. These include a PGD for live attenuated influenza vaccine (the LAIV PGD), and a separate inactivated influenza vaccine PGD. Practitioners must not use these PGDs until they have been authorised in Section 2. This is a legal requirement in accordance with the Human Medicines Regulations 2012. Practitioners should follow local policy/procedures to access authorised PGD documents.

There is a separate PGD for the community pharmacy seasonal influenza vaccine service which is authorised nationally by NHSE and published on the associated NHS webpage for the community pharmacy seasonal influenza vaccine service.

National protocol for inactivated influenza vaccine

For the 2024 to 2025 influenza season, there is a national protocol for the administration of inactivated influenza vaccine to individuals eligible for vaccination as part of the nationally commissioned influenza vaccination programme. The national protocol allows for a mixed workforce model for vaccination similar to that used for COVID-19 vaccination. In accordance with the national protocol for inactivated influenza vaccine, administration of inactivated influenza vaccine may be by appropriately trained persons, following assessment of the individual by a specified registered professional as detailed in the national protocol.

Public-facing marketing campaign

This year the national marketing campaign which supports uptake of this winter’s essential vaccinations – influenza and COVID-19 vaccines – will launch week commencing 7 October. The integrated campaign supports both vaccination programmes, targeting cohorts where uptake is traditionally lower: pregnant women, parents of 2- to 3-year-olds (flu only) and those with long-term health conditions.

The campaign narrative sets out that both influenza and COVID-19 spread more easily in winter and can be life-threatening, but that those eligible can protect themselves by having the flu and COVID-19 vaccinations, helping to reduce the serious illness these diseases can cause, should they catch one of them. The call to action is: Get Vaccinated. Get Winter Strong.

There will also be activity aimed at encouraging pregnant women to get the pertussis and RSV vaccines when eligible.

The campaign will launch with TV advertising, broadcast radio, digital and multicultural marketing advertising supported by search, PR and partnership activity.

Printed materials will be available from the Campaign Resource Centre.

Communications toolkit

UKHSA, NHSE and the Department for Health and Social Care have produced a communications toolkit which provides information on the flu and COVID-19 vaccination programme for 2024 to 2025, with both public-facing and staff-facing messages. It aims to support stakeholders to explain and promote the vaccination programmes to those eligible. It contains background information, statistics, key messages, suggested social media copy, social media assets and links to useful information.

Disease surveillance and vaccine uptake data

Influenza and COVID-19 disease surveillance reporting is combined into one report to create the ‘Weekly national Influenza and COVID-19 Surveillance Report’ which is published weekly on Thursdays at 2pm. For the 2024 to 2025 season the data will be available on the statistics webpage.

The report summarises information from the surveillance systems which are used to monitor influenza, SARS-CoV-2 (the virus that causes COVID-19), and other seasonal respiratory viruses in England. As per previous seasons from week 41 (10 October 2024) onwards national-level ‘top lines’ on weekly vaccine uptake for pregnant women, clinical at-risk groups, 65 year and over and 2- and 3-year-olds will be included in the weekly surveillance report.

The government’s official statistics on vaccine coverage for eligible GP-registered patients, school-aged children and frontline healthcare workers are managed through the ImmForm website. This data is used to formally evaluate the programme year on year and is reported annually to the World Health Organization. For the 2024 to 2025 season monthly vaccine uptake will be published as official statistics at 2pm on the following dates:

Frontline HCWs Survey (Flu and Covid-19) Publication Date 2pm
October Thu 28/11/2024
November Thu 19/12/2024
December 30/01/2025
January 27/02/2025
February 27/03/2025
GP Survey Month Publication Date 2pm
October Thu 28/11/2024
November Thu 19/12/2024
December 30/01/2025
January 27/02/2025
February 27/03/2025
School Age Manual Survey Collection Publication Date 2pm
October Thu 28/11/2024
November Thu 19/12/2024
December 30/01/2025
January 27/02/2025

Further communication on data collection tools, collection timelines and user guides will be shared with stakeholders separately. For any queries related to the data collections or official statistics, please contact the relevant mailbox as follows:

Links to the monthly data for the 2024 to 2025 season will be published on the vaccine uptake webpage.

Note that as for previous seasons there will be specific webpages for each collection, but the webpage addresses are not available in advance of the pages being published. However, the collections will be named as follows:

  • seasonal influenza vaccine uptake in school age children: winter season 2024 to 2025
  • seasonal influenza vaccine uptake in frontline healthcare workers in England: winter season 2024 to 2025
  • seasonal influenza vaccine uptake in GP patients in England: winter season 2024 to 2025

Vaccines for the 2024 to 2025 children’s flu programme supplied by UKHSA

All flu vaccines for the 2024 to 2025 children’s flu programme will be available to order by NHS providers in England via ImmForm.

UKHSA does not supply any flu vaccines for patients aged 18 years and over.

Please refer to guidance from your respective health departments for arrangements in Scotland, Wales and Northern Ireland.

Important update regarding the live attenuated influenza vaccine

From 2024 LAIV will be a trivalent vaccine (rather than quadrivalent) due to the removal of the B-Yamagata strain. This change in formulation by AstraZeneca was recommended by the World Health Organization and is supported by the JCVI. The brand name for the trivalent vaccine is Fluenz® (the quadrivalent vaccine was named Fluenz® Tetra).

Presentation of the vaccine (for example, pre-filled single dose nasal spray, supplied in a 10-dose pack) remains the same, and LAIV will be available to order via ImmForm for providers of the children’s flu programme as usual.

Vaccines and availability

The 2 vaccines that will be available, preliminary indicative ordering dates, and the groups that these vaccines should be ordered for are set out in the table below. At present these timings remain subject to change.

The latest and most accurate information on availability of centrally supplied vaccines for the children’s flu programme is available on the ImmForm news page at all times. It is strongly advised that all parties involved in the provision of influenza vaccines to children ensure they remain up to date with this.

Vaccine Manufacturer Available to order for Anticipated order opening for all providers
Fluenz® (LAIV) AstraZeneca All children from 2 years of age to school year 11 Children in clinical risk groups aged 2 to <18 years* Week commencing 2 September (with first deliveries week commencing 9 September)
Cell Based Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) (QIVc) Seqirus Children in clinical risk groups aged 6 months to <2 years All other eligible** children aged 2 to <18 years for whom LAIV is unsuitable Week commencing 2 September

Editing Fluenz® (LAIV) orders

Due to the anticipated large volume of orders for Fluenz® in the first few weeks of ordering, orders for this product will be assembled as soon as they are placed and will not be editable. If you need to make an adjustment to your order after it has been placed, you will need to contact helpdesk@immform.org.uk for assistance.

LAIV ordering information for general practice

Ordering controls will be in place for general practices, to enable UKHSA to balance supply with demand. These controls will work by allocating an amount of LAIV based on the number of registered eligible patients and will be tailored to each practice. GPs will be able to place 1 order and receive 1 delivery of LAIV per week.

UKHSA expects to be able to accommodate the following, however at this time, this information remains subject to change:

  • each GP practice will initially be allocated sufficient LAIV to vaccinate at least 45% of their eligible patients (all 2- and 3-year-olds, plus children in clinical risk groups from age 4 to <18 years) when ordering commences
  • increases to these allocations will be made in response to demand and vaccine availability
  • requests for extra vaccine will be considered on a case-by-case basis throughout the ordering period. Requests for additional vaccine should be sent to helpdesk@immform.org.uk and should be sent in good time before your order cut-off. Out of schedule deliveries will be by exception only

Multi-branch practices and LAIV allocations

Please note that GP practices or groups that operate over multiple sites but are part of the same organisation will have a joint allocation (as in previous years), even where each site has a unique ImmForm account. This means that it is possible for one site to potentially order all of the available vaccine for the group, unless there is local agreement on how the allocated volume is shared. UKHSA recommends that this agreement is in place before ordering opens to reduce the risk of supply interruption. The information above allows practices to estimate the amount of vaccine they will be initially allocated, and how it should be split between all sites.

LAIV ordering information for school-age providers

School providers are able to place 2 orders and receive 2 deliveries of LAIV per week, to assist in the management of vaccine volumes required across limited storage space at delivery points.

This operates on a 48-hour delivery schedule requiring the order to be placed before the 11:55am cut-off 2 working days before the required delivery day. The table below illustrates the respective delivery days versus ordering day.

Order day (before 11:55am cut-off) Delivery day
Monday Wednesday
Tuesday Thursday
Wednesday Friday
Thursday Monday
Friday Tuesday

Customers must ensure that the point of delivery will be open and staffed between 9am and 5pm on the delivery day when placing orders.

Please note that this does not affect the routine ordering and delivery schedule of any other vaccines (including inactivated flu vaccines) ordered from ImmForm and is applicable to Fluenz® (LAIV) only.

A default weekly ordering cap of 450 packs (4,500 doses) per week will be in place for school provider accounts.

Where this cap is insufficient and a provider needs a larger weekly volume of vaccine to deliver the programme (for example where a provider covers a large area using a single account), a higher weekly cap should be requested via the UKHSA Flu Vaccine Operations team by emailing childfluvaccine@ukhsa.gov.uk.

For one-off larger orders during the ordering period, requests should be made via helpdesk@immform.org.uk.

Inactivated flu vaccine ordering

The Cell Based Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) (QIVc) will be available to order, in a single-dose pack, for:

  • children in clinical risk groups aged from six months to less than 2 years old
  • children aged from 2 to <18 years old in clinical risk groups for whom LAIV is clinically contraindicated or otherwise unsuitable
  • healthy children from 2 years old to those in school year 11, for whom LAIV is unsuitable (for example, due to objection to LAIV on the grounds of its porcine gelatine content)

Order controls will also be in place for this vaccine as follows:

  • for GPs, there will be an initial cap of 10 doses/packs per week
  • for school-age providers, there will be a cap of 450 doses/packs per week

All influenza vaccines for the 2024 to 2025 season

Information on all influenza vaccines that have been marketed in the UK for the 2024 to 2025 season are available on this webpage.

Flu publications available to order

Leaflets remain an effective way of communicating the benefits of having a flu vaccine and inform about the consent process. It is important that people receive a leaflet in a format that meets their needs, with accessible versions being an important way to improve uptake in underserved communities. We also want everyone to have a positive vaccination experience and having accessible information is part of that experience.

Our leaflets and resources are all available to download and many can also be ordered for free. We have a wide range of leaflets in translated versions, simple text, large print, Braille, audio, British Sign Language (BSL) versions, and easy read and video for those who have a learning disability.

There are also HTML versions which are text-only. This helps search engines on the web that look for content, people who use screen readers and assisted technology. HTML versions can also be signposted to in e-consent forms which need to include leaflets when asking for consent. If using e-consent it is important to recognise that not all parents and carers have access to digital resources, so it is important to provide printed leaflets as well.

Schools and the school-aged immunisation service can identify which accessible versions would be helpful for their cohorts. For example, if there are students who are deaf or use BSL, they can make the videos available on screens or share the link with parents and children. It is important to recognise that many BSL users rely on BSL resources as written literacy in this group can be lower.

Stay up to date with all of the publications to support the annual flu programme.

Main leaflets

These new posters and leaflets promoting awareness of the flu vaccine are available to download from the Health Publications website.

Protect your child against flu – Information for parents and carers of children in primary school or pre-school

This leaflet is for parents and carers. It explains why children are eligible for a flu vaccination, as well as describing the disease and the nasal flu vaccine. It is available using product code 2023FCEN.

This leaflet is available in the following languages:

This leaflet is also available in the following formats:

Protect yourself against flu – Information for those in secondary school

This leaflet is aimed at young people and explains why they are eligible for a flu vaccination, as well as describing the disease and the nasal flu vaccine. It is availabe using product code 22SECFLUEN.

This leaflet is available in the following languages:

This leaflet is also available in the following formats:

When should I get my flu vaccine?

This leaflet explains why adults eligible for the flu vaccine will be offered a flu vaccine from early October this year. This is based on the latest scientific evidence that shows that protection from the flu vaccine decreases over time in adults. It is therefore better to have the vaccine closer to when flu typically circulates. This leaflet is available using product code 24FLUWEN.

The flu vaccination – Who should have it and why

This leaflet explains to patients how they can help protect themselves and their children against flu this winter. It includes information about eligible children, adults and pregnant women. It is available in accessible formats such as audio, Braille, BSL video and large print. Translations will be available in due course. The main leaflet is available using product code FLUMW24EN.

Guidance and resources for schools

Flu vaccination – Briefing for primary schools

This guide gives details about the flu vaccination programme for primary school-aged children including how the programme is delivered and the role schools play. It can be downloaded and ordered for free using product code FLUPY24.

Adolescent vaccination programme – Briefing for secondary schools

This guide explains the NHS adolescent vaccination programmes delivered to children in secondary schools and the important role that schools play in the delivery of them. It can be downloaded and ordered for free at using product code FLUSY24.

A flu vaccine consent form (covering both the nasal spray vaccine and flu vaccine by injection) is available for school-aged immunisation service providers to download.

Letter template inviting school-aged children for vaccination

A letter template is available for school-aged immunisation provider teams to use.

Flu: 5 reasons to vaccinate your child poster 0-11 years

This poster has been updated for 2024 to 2025. It is aimed at parents and explains the benefits of vaccinating children against flu. It is available using product code FLU5RY24EN.

This poster is also available in the following languages:

Flu: 5 reasons to have the vaccine – secondary school

This poster has been updated for 2024 to 2025. It is aimed at young people and explains the benefits of having the flu vaccine. It is available using product code FLU5RS24.

This poster is also available in the following languages:

Stickers

Stickers are available for healthcare practitioners to give to children who have received a flu vaccine either at their GP practice or school. There are 72 stickers per sheet. These can be ordered using product code SCHFLSTK.

Simple text versions

Aimed at individuals with a low reading age, simple text versions of the ‘All about flu and how to stop getting it’ leaflet are available to download and order for free, using product code FLU2023STA for adults and product code FLU2021STC for children.

Resources for those with a learning disability

Several resources are available for those with a learning disability. They are aimed at people who have a learning disability or who care for someone with a learning disability. They provide advice on the flu virus and why you need a vaccine every year.

Protect yourself from flu: easy-read leaflet

This can be downloaded and ordered for free using product code EASYREADFLU1.

Protect yourself from flu: easy-read poster

This can be downloaded and ordered for free using product code EASYREADFLU2.

Flu vaccination films for people with a learning disability and autistic people and their family or carers

There are 2 short films about the importance of flu vaccination for people with a learning disability and autistic people with certain health conditions.

The films cover why it is important, who is eligible for a free vaccine, where you can get the vaccine and reasonable adjustments. They are available to watch here and here.

Reasonable adjustments

The importance and range of reasonable adjustments that can be made so people with a learning disability or other disabilities have good access to healthcare is explained in this film. Resources and tools to support this legal requirement can be found on the NHSE webpage.

Flu vaccination for pre-school children

Immunising pre-school children against flu

Available to download, this leaflet is about the annual flu vaccination programme for pre-school children. It informs those working in the early years sector about the programme and how they can support it. It is aimed at nursery and pre-school managers and staff, and childminders delivering the Early Years Foundation Stage Framework, and those who provide informal childcare, such as nannies.

Letter templates for general practice

Flu vaccination: letter template for children aged 2 and 3 years

GP practices can use this template to invite parents and guardians to get their child vaccinated at their local surgery.

Flu vaccination: letter template for at-risk patients and carers

GPs can use this template to invite patients at risk from flu due to a medical condition, pregnancy or age, and those who receive a carer’s allowance or are the main carer for an older or disabled person, to have their annual flu vaccine.

GP best practice guidance: Increasing flu vaccine uptake in pre-school children

This resource sets out steps that GPs can take to improve flu vaccine uptake in children aged 2 and 3 years old.

British Islamic Medical Association flu resources

The British Islamic Medical Association (BIMA) has updated their 2 resources which explain the benefits of flu vaccination, the Islamic position on taking up the vaccine, and how to weigh up whether your children should have the nasal spray vaccine given the porcine gelatine content and conflict with a halal diet. BIMA are happy to be contacted for any local queries on info@britishima.org and you can download these resources from their website.

  1. Of the eligible cohorts listed above, those marked with an asterisk may be vaccinated by any general practice, regardless of whether they are registered with that general practice. ↩ ↩2 ↩3 ↩4 ↩5

Back to top